Home/Filings/4/0001628280-23-003706
4//SEC Filing

NEIL GARRY ARTHUR 4

Accession 0001628280-23-003706

CIK 0001534120other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:16 PM ET

Size

5.6 KB

Accession

0001628280-23-003706

Insider Transaction Report

Form 4
Period: 2023-02-13
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-13+100,000100,000 total
    Exercise: $2.98Exp: 2033-02-13Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001586785

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:16 PM ET
Size
5.6 KB